Chronic nicotine interactions with clozapine and risperidone and attentional function in rats

Area of Science:

• Neuroscience
• Psychopharmacology
• Cognitive Science

Background:

• Antipsychotic medications improve schizophrenia symptoms but not cognitive function.
• Attentional deficits persist in schizophrenia, potentially worsened by antipsychotics.
• Nicotine self-administration is common in schizophrenia and may improve cognition.

Purpose of the Study:

• To investigate the interactive effects of clozapine and risperidone with chronic nicotine on attentional performance.
• To determine if nicotine can mitigate antipsychotic-induced attentional impairments.

Main Methods:

• Adult female rats were trained on an operant visual signal detection task.
• Rats received chronic nicotine (5 mg/kg/day) or saline via osmotic pump for 28 days.
• Acute doses of clozapine or risperidone were administered, and attentional function was assessed.

Main Results:

• Acute clozapine and risperidone impaired attentional accuracy in saline-treated rats.
• Chronic nicotine alone reduced accuracy but attenuated the impairments caused by acute clozapine and risperidone.
• Clozapine was more detrimental than risperidone; nicotine masked the adverse effects of both.

Conclusions:

• Atypical antipsychotics clozapine and risperidone impair attentional performance.
• Chronic nicotine administration can attenuate these drug-induced attentional deficits.
• Nicotine may play a role in managing cognitive impairments in schizophrenia patients treated with these antipsychotics.